DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+4.82%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.25B
AUM Growth
+$2.25B
(+3.1%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
37.85%
Holding
149
New
29
Increased
29
Reduced
29
Closed
26
Top Buys
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$74.2M |
| 2 |
eHealth
EHTH
|
$40M |
| 3 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$38.2M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$37M |
| 5 |
ITMN
INTERMUNE INC
ITMN
|
$32.3M |
Top Sells
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$94.5M |
| 2 |
Labcorp
LH
|
$57.2M |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$32.1M |
| 4 |
AbbVie
ABBV
|
$27.3M |
| 5 |
Merck
MRK
|
$27.1M |
Sector Composition
| 1 | Healthcare | 46.87% |
| 2 | Financials | 2.85% |
| 3 | Technology | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUXL
1
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $126M | 5.06% | 6,267,382 +3,700,677 | +144% | +$74.2M |
|
|
ITMN
2
DELISTED
INTERMUNE INC
ITMN
| $102M | 4.11% | 2,315,521 +731,579 | +46% | +$32.3M |
|
|
AVDL
3
Avadel Pharmaceuticals
AVDL
$1.43B
| $78.9M | 3.17% | 5,258,475 | – | – |
|
|
AGN
4
DELISTED
ALLERGAN INC
AGN
| $73.5M | 2.95% | 434,199 +218,563 | +101% | +$37M |
|
|
NXTM
5
DELISTED
NxStage Medical Inc.
NXTM
| $70.4M | 2.83% | 4,899,721 +1,098,546 | +29% | +$15.8M |
|
|
KERX
6
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $59.7M | 2.4% | 3,884,409 +2,481,304 | +177% | +$38.2M |
|
|
ARRY
7
DELISTED
Array Biopharma Inc
ARRY
| $55.7M | 2.24% | 12,205,673 | – | – |
|
|
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $54.8M | 2.2% | 2,428,569 | – | – |
|
|
9
eHealth
EHTH
$118M
| $50.2M | 2.02% | 1,323,391 +1,052,391 | +388% | +$40M |
|
|
UAM
10
DELISTED
Universal American Corp
UAM
| $48.1M | 1.93% | 5,771,737 +1,170,744 | +25% | +$9.75M |
|
|
INFI
11
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $46.8M | 1.88% | 3,674,838 -769,189 | -17% | -$9.8M |
|
|
ASPX
12
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $44.2M | 1.78% | 1,984,038 -4,952 | -0.2% | -$110K |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| $41.5M | 1.67% | 1,075,268 +660,794 | +159% | +$25.5M |
|
14
DaVita
DVA
$9.85B
| $41M | 1.65% | 566,588 +218,577 | +63% | +$15.8M |
|
|
DYAX
15
DELISTED
DYAX CORPORATION
DYAX
| $35.7M | 1.43% | 3,717,013 -69,465 | -2% | -$667K |
|
|
AERI
16
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $33.5M | 1.35% | 1,350,850 +785,670 | +139% | +$19.5M |
|
|
17
AbbVie
ABBV
$372B
| $30.6M | 1.23% | 541,400 -483,600 | -47% | -$27.3M |
|
18
Pacific Biosciences
PACB
$393M
| $29M | 1.17% | 4,695,203 -710,907 | -13% | -$4.39M |
|
19
McKesson
MCK
$85.4B
| $27.9M | 1.12% | 150,000 -13,000 | -8% | -$2.42M |
|
|
RNA
20
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $27.8M | 1.12% | 2,206,119 -1,005,253 | -31% | -$12.7M |
|
|
ATRS
21
DELISTED
Antares Pharma, Inc.
ATRS
| $25.6M | 1.03% | 9,603,703 +115,242 | +1% | +$308K |
|
|
ARNA
22
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $25.6M | 1.03% | 4,369,066 +3,152,487 | +259% | +$18.5M |
|
23
Insmed
INSM
$28.8B
| $24.1M | 0.97% | 1,205,234 -810,913 | -40% | -$16.2M |
|
|
ZLTQ
24
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $23.8M | 0.96% | 1,566,155 +1,082,635 | +224% | +$16.4M |
|
|
TRIV
25
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $23.1M | 0.93% | +1,482,666 | New | +$23.1M |
|